問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Find Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
蘇柏榮
下載
2018-09-01 - 2022-12-31
Condition/Disease
Hepatocellular Carcinoma (HCC)
Test Drug
nivolumab﹝Opdivo﹞/ ipilimumab ﹝Yervoy﹞
Participate Sites9Sites
Recruiting8Sites
2022-01-01 - 2024-12-31
Metastatic Prostate Cancer
Ga-68 PSMA ligand
Participate Sites1Sites
Recruiting1Sites
2020-12-01 - 2022-03-22
Participate Sites4Sites
Recruiting4Sites
2019-11-01 - 2023-01-31
Biliary Tract Cancer
Bintrafusp alfa (M7824)
Participate Sites7Sites
Recruiting7Sites
2021-06-01 - 2022-05-30
Participate Sites6Sites
Recruiting6Sites
2016-01-01 - 2021-05-31
Cholangiocarcinoma
CX-4945
未分科
Division of Hematology & Oncology
2021-09-01 - 2023-08-09
Participate Sites3Sites
Recruiting3Sites
全部
